Close the gap in pediatric genomic care (opens in new tab)
We are at an inflection point in pediatric healthcare. Across the U.S., health plans are increasingly recognizing the clinical and economic value of genomic testing. Policies are expanding. Coverage is improving. For families navigating complex, often unexplained conditions, that progress matters. But coverage alone does not guarantee care. As a physician who has practiced at the bedside and worked within the payer system, I’ve seen this gap from both sides. For children with suspected rare d...
Read the original article